Alosetron for severe diarrhea-predominant irritable bowel syndrome: safety and efficacy in perspective.
about
Optimizing outcomes with alosetron hydrochloride in severe diarrhea-predominant irritable bowel syndrome.A 9-year evaluation of temporal trends in alosetron postmarketing safety under the risk management program.The risk of ischaemic colitis in irritable bowel syndrome patients treated with serotonergic therapies.Agents that act luminally to treat diarrhoea and constipation.Evaluating the functional net value of pharmacologic agents in treating irritable bowel syndrome.How the FDA manages drug safety with black box warnings, use restrictions, and drug removal, with attention to gastrointestinal medications.Pathological Conditions Associated with the Disturbance of the 5-HT System
P2860
Q34409173-CD03C7BF-8DCF-481C-8440-8E99C4B5BA37Q37130608-5C3111C4-592B-4359-A8BA-3A5F0B686DF4Q37887773-2FB113C8-EFB1-4379-AE30-17724C4414F5Q38040321-E327B3C2-6B9E-436A-A484-563E60F1EC82Q38194631-3E5BBC5F-9A6F-471A-AB2C-8CDA81729DA9Q45911336-0EE80135-BC6A-4A1A-BD2F-D7BF25A8433BQ59201274-366ADF2A-C46E-4C44-8BDE-A9C7F4A28A2A
P2860
Alosetron for severe diarrhea-predominant irritable bowel syndrome: safety and efficacy in perspective.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Alosetron for severe diarrhea- ...... y and efficacy in perspective.
@en
Alosetron for severe diarrhea- ...... y and efficacy in perspective.
@nl
type
label
Alosetron for severe diarrhea- ...... y and efficacy in perspective.
@en
Alosetron for severe diarrhea- ...... y and efficacy in perspective.
@nl
prefLabel
Alosetron for severe diarrhea- ...... y and efficacy in perspective.
@en
Alosetron for severe diarrhea- ...... y and efficacy in perspective.
@nl
P2860
P356
P1476
Alosetron for severe diarrhea- ...... y and efficacy in perspective.
@en
P2093
James H Lewis
P2860
P356
10.1586/EGH.09.72
P577
2010-02-01T00:00:00Z